Magnesium Sulfate Administration in Moderate Coronary Artery Disease Patients Improves Atherosclerotic Risk Factors: A Double-Blind Clinical Trial Study-Reference-Cited by-同舟云学术

Magnesium Sulfate Administration in Moderate Coronary Artery Disease Patients Improves Atherosclerotic Risk Factors: A Double-Blind Clinical Trial Study

Published:2020-09 Issue:3 Volume:76 Page:321-328
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Farshidi Hossein,Sobhani Ali R.,Eslami Mahdiye,Azarkish Fariba,Eftekhar Ebrahim,Keshavarz Mansoor,Soltani Nepton

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference24 articles.

1. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat;Soltani;Eur J Pharmacol.,2007

2. Effect of oral magnesium sulfate administration on lectin-like oxidized low-density lipoprotein receptor-1 gene expression to prevent atherosclerosis in diabetic rat vessels;Fazlali;J Diabetes Investig.,2019

3. Magnesium for atherosclerosis;Browne;Br Med J.,1964

4. Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels;Brinkley;Exp Physiol.,2008

5. Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women;Brinkley;Obesity.,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of magnesium sulfate on gene expression and serum level of inflammatory cytokines in coronary artery disease patients;Inflammopharmacology;2023-09-04

2. Magnesium Deficiency and Cardiometabolic Disease;Nutrients;2023-05-17

3. The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients;Current Issues in Molecular Biology;2023-04-05

4. Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review;Nutrients;2021-04-22